Eurosurveillance | MenC conjugate vaccine in Europe – schedules, protection and outcomes

1887

Articles Open Access

Like 0

This item has no PDF Download

MenC conjugate vaccine in Europe – schedules, protection and outcomes
J Bowley
View Citation Hide Citation

Citation style for this article: J Bowley. MenC conjugate vaccine in Europe – schedules, protection and outcomes. Euro Surveill. 2004;8(32):pii=2519. https://doi.org/10.2807/esw.08.32.02519-en

Abstract

A recently published report confirms that MenC vaccine provides high protection during four years of follow up.

©

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Article metrics loading...

/content/10.2807/esw.08.32.02519-en

2004-08-05

2024-12-26

Click here for cited by

/content/10.2807/esw.08.32.02519-en

Loading full text...

Full text loading...

/deliver/fulltext/eurosurvweeklyarchive/8/32/art02519-en.htm?itemId=/content/10.2807/esw.08.32.02519-en&mimeType=html&fmt=ahah

Submit comment

Close

Comment moderation successfully completed

Submit your article here

Submit an Article

Tools

Related Content

From This Site

/content/10.2807/esw.08.32.02519-en

dcterms_title,dcterms_subject,pub_keyword

-contentType:Journal -contentType:Contributor -contentType:Concept -contentType:Institution

10

5
PubMed
- PubMed citation
- J Bowley
Google Scholar
- J Bowley
- Search for related Content

This is a required field

Please enter a valid email address

Approval was a Success

Invalid data

An Error Occurred

Approval was partially successful, following selected items could not be processed due to error